i-SENS

i-SENS, founded in 2000, is a prominent manufacturer in the medical devices and equipment industry. The company is globally recognized for its CareSens® brand, which delivers high-precision blood glucose monitoring solutions. By prioritizing accuracy and rapid testing, i-SENS has established a significant footprint in the global healthcare market, serving patients and professionals across more than 110 countries, including major markets in the USA, Japan, and Europe.

The company maintains a robust operational scale, supported by a workforce of 500-1,000 employees. i-SENS operates highly efficient manufacturing facilities with an annual production capacity of 2.2 billion test strips. These facilities, located across Korea and China, ensure consistent supply chain reliability for their international distribution network. With two primary locations, the firm maintains strict quality control standards to meet the rigorous demands of the global medical device sector.

Beyond glucose monitoring, i-SENS collaborates with healthcare professionals to develop advanced point-of-care testing (POCT) devices, including electrolyte and blood gas analyzers. The company is also preparing for the near-future launch of its continuous glucose monitoring (CGM) system. Holding the No. 1 market share position in Korea, i-SENS continues to innovate under the ticker KRX: 099190. Meet i-SENS's team to learn more about the leadership driving these technological advancements in medical diagnostics.